HAMILTON LANE INC-CLASS A (HLNE)

US4074971064 - Common Stock

199.55  +1.38 (+0.7%)

After market: 199.55 0 (0%)

Fundamental Rating

6

HLNE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 220 industry peers in the Capital Markets industry. HLNE scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HLNE is valued quite expensively, but it does show have an excellent growth rating. With these ratings, HLNE could be worth investigating further for growth and quality investing!.



8

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
In the past year HLNE had a positive cash flow from operations.
Each year in the past 5 years HLNE has been profitable.
In the past 5 years HLNE always reported a positive cash flow from operatings.

1.2 Ratios

HLNE's Return On Assets of 12.76% is amongst the best of the industry. HLNE outperforms 93.09% of its industry peers.
The Return On Equity of HLNE (29.97%) is better than 95.85% of its industry peers.
With an excellent Return On Invested Capital value of 22.22%, HLNE belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HLNE is significantly above the industry average of 6.97%.
The 3 year average ROIC (19.34%) for HLNE is below the current ROIC(22.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.76%
ROE 29.97%
ROIC 22.22%
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%

1.3 Margins

HLNE has a better Profit Margin (28.03%) than 70.97% of its industry peers.
HLNE's Profit Margin has improved in the last couple of years.
HLNE has a Operating Margin of 45.03%. This is in the better half of the industry: HLNE outperforms 74.65% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 45.03%
PM (TTM) 28.03%
GM N/A
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

HLNE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HLNE has been increased compared to 5 years ago.
The debt/assets ratio for HLNE has been reduced compared to a year ago.

2.2 Solvency

HLNE has an Altman-Z score of 9.61. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
HLNE has a better Altman-Z score (9.61) than 95.85% of its industry peers.
HLNE has a debt to FCF ratio of 1.12. This is a very positive value and a sign of high solvency as it would only need 1.12 years to pay back of all of its debts.
The Debt to FCF ratio of HLNE (1.12) is better than 86.18% of its industry peers.
HLNE has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.32, HLNE is doing good in the industry, outperforming 76.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.12
Altman-Z 9.61
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.92 indicates that HLNE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.92, HLNE is in line with its industry, outperforming 41.94% of the companies in the same industry.
HLNE has a Quick Ratio of 0.92. This is a bad value and indicates that HLNE is not financially healthy enough and could expect problems in meeting its short term obligations.
HLNE has a Quick ratio (0.92) which is comparable to the rest of the industry.
The current and quick ratio evaluation for HLNE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92

7

3. Growth

3.1 Past

HLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.03%, which is quite impressive.
Measured over the past years, HLNE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.47% on average per year.
Looking at the last year, HLNE shows a very strong growth in Revenue. The Revenue has grown by 31.89%.
Measured over the past years, HLNE shows a quite strong growth in Revenue. The Revenue has been growing by 17.04% on average per year.
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%20.22%
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%18.22%

3.2 Future

The Earnings Per Share is expected to grow by 17.56% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.68% on average over the next years. This is quite good.
EPS Next Y29.69%
EPS Next 2Y18.57%
EPS Next 3Y17.56%
EPS Next 5YN/A
Revenue Next Year31.51%
Revenue Next 2Y19.4%
Revenue Next 3Y17.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.73, HLNE can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 78.80% of the companies listed in the same industry.
HLNE's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 29.29.
HLNE is valuated quite expensively with a Price/Forward Earnings ratio of 36.21.
75.12% of the companies in the same industry are cheaper than HLNE, based on the Price/Forward Earnings ratio.
HLNE is valuated expensively when we compare the Price/Forward Earnings ratio to 24.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.73
Fwd PE 36.21

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HLNE.
Based on the Price/Free Cash Flow ratio, HLNE is valued a bit more expensive than the industry average as 62.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 63.37
EV/EBITDA 36.61

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HLNE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HLNE's earnings are expected to grow with 17.56% in the coming years.
PEG (NY)1.44
PEG (5Y)2.76
EPS Next 2Y18.57%
EPS Next 3Y17.56%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.99%, HLNE is not a good candidate for dividend investing.
HLNE's Dividend Yield is slightly below the industry average, which is at 8.96.
Compared to an average S&P500 Dividend Yield of 2.19, HLNE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 26.37%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)26.37%
Div Incr Years6
Div Non Decr Years6

5.3 Sustainability

38.88% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP38.88%
EPS Next 2Y18.57%
EPS Next 3Y17.56%

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (11/22/2024, 8:00:00 PM)

After market: 199.55 0 (0%)

199.55

+1.38 (+0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.06B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 42.73
Fwd PE 36.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.44
PEG (5Y)2.76
Profitability
Industry RankSector Rank
ROA 12.76%
ROE 29.97%
ROCE
ROIC
ROICexc
ROICexgc
OM 45.03%
PM (TTM) 28.03%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y
EPS Q2Q%
EPS Next Y29.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y